Literature DB >> 24094725

Genetic defects in Indian Wilson disease patients and genotype-phenotype correlation.

Shashwata Mukherjee1, Shruti Dutta1, Sulagna Majumdar1, Tamoghna Biswas1, Preeti Jaiswal1, Mainak Sengupta1, Abhisek Bhattacharya1, Prasanta K Gangopadhyay2, Ashish Bavdekar3, Shyamal K Das4, Kunal Ray5.   

Abstract

Wilson disease (WD) is caused by defects in ATP7B gene due to impairment of normal function of the copper transporting P-type ATPase. This study describes a comprehensive genetic analysis of 199 Indian WD patients including mutations detected in our previous studies, undertakes functional assessment of the nucleotide variants in ATP7B promoter and correlates genotype with disease phenotype. The patient cohort harbors a total of 10 common and 48 rare mutations in the coding region of ATP7B including 21 novel changes. The common mutations represent 74% of characterized coding mutant alleles with p.C271X (63/260) and p.G1101R (7/31) being the most prevalent in eastern and western Indian patients, respectively. The mutation spectrum between east and west is mostly different with only three mutations (p.G1061E, p.N1270S and p.A1049A-fs) being shared between both the groups. Eight novel and 10 reported variants have been detected in the promoter and non-coding regions (5' and 3'UTRs) of ATP7B. Promoter reporter assay demonstrated that 3 novel variants and 5 reported polymorphisms alter the gene expression to a considerable extent; hence might play important role in ATP7B gene regulation. We devised the neurological involvement score to capture the spectrum of neurological involvement in WD patients. By utilizing the age at onset, neurological involvement score and ATP7B mutation background, we generated a genotype-phenotype matrix that could be effectively used to depict the phenotypic spectra of WD affected individuals and serve as a platform to identify prospective "outliers" to be investigated for their remarkable phenotypic divergence.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATP7B; Genotype–phenotype correlation; WD; Wilson disease

Mesh:

Substances:

Year:  2013        PMID: 24094725     DOI: 10.1016/j.parkreldis.2013.09.021

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  15 in total

Review 1.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

2.  Genetic analysis of 55 northern Vietnamese patients with Wilson disease: seven novel mutations in ATP7B.

Authors:  Le Anh Tuan Pham; Trong Tue Nguyen; Hoang Bich Nga Le; Dat Quoc Tran; Cam Tu Ho; Thinh Huy Tran; Van Thanh Ta; The Hung Bui; Van Khanh Tran
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

3.  Correlation of ATP7B gene mutations with clinical phenotype and radiological features in Indian Wilson disease patients.

Authors:  Jasodhara Chaudhuri; Samar Biswas; Goutam Gangopadhyay; Tamoghna Biswas; Jyotishka Datta; Atanu Biswas; Alak Pandit; Amlan Kusum Datta; Adreesh Mukherjee; Atanu Kumar Dutta; Paramita Bhattacharya; Avijit Hazra
Journal:  Acta Neurol Belg       Date:  2021-10-13       Impact factor: 2.396

4.  An MTF1 binding site disrupted by a homozygous variant in the promoter of ATP7B likely causes Wilson Disease.

Authors:  Heidi I Chen; Karthik A Jagadeesh; Johannes Birgmeier; Aaron M Wenger; Harendra Guturu; Susan Schelley; Jonathan A Bernstein; Gill Bejerano
Journal:  Eur J Hum Genet       Date:  2018-08-07       Impact factor: 4.246

Review 5.  Modifying factors and phenotypic diversity in Wilson's disease.

Authors:  Svetlana Lutsenko
Journal:  Ann N Y Acad Sci       Date:  2014-04-04       Impact factor: 5.691

6.  Potential Role of Brain-Derived Neurotrophic Factor and Dopamine Receptor D2 Gene Variants as Modifiers for the Susceptibility and Clinical Course of Wilson's Disease.

Authors:  Shubhrajit Roy; Prosenjit Pal; Sampurna Ghosh; Sreyashi Bhattacharya; Shyamal Kumar Das; Prasanta Kumar Gangopadhyay; Ashish Bavdekar; Kunal Ray; Mainak Sengupta; Jharna Ray
Journal:  Neuromolecular Med       Date:  2018-07-10       Impact factor: 3.843

Review 7.  The Pragmatic Treatment of Wilson's Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

Review 8.  The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.

Authors:  Candan Ariöz; Yaozong Li; Pernilla Wittung-Stafshede
Journal:  Biometals       Date:  2017-10-23       Impact factor: 2.949

Review 9.  Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?

Authors:  Carmen Espinós; Peter Ferenci
Journal:  JHEP Rep       Date:  2020-04-18

10.  Genetic analysis of ATP7B in 102 south Indian families with Wilson disease.

Authors:  Nivedita Singh; Pradeep Kallollimath; Mohd Hussain Shah; Saketh Kapoor; Vishwanath Kumble Bhat; Lakshminarayanapuram Gopal Viswanathan; Madhu Nagappa; Parayil S Bindu; Arun B Taly; Sanjib Sinha; Arun Kumar
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.